| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/21/2011 | EP0725791B1 Recombinant p53 adenovirus methods and compositions |
| 09/21/2011 | CN1972710B Methods and compositions comprising bacteriophage nanoparticles |
| 09/21/2011 | CN1952129B Angptl4 deletion mutant and application thereof |
| 09/21/2011 | CN1927883B Novel cytokine zalpha11 ligand |
| 09/21/2011 | CN1919868B Chronic neuralgia related albumen and gene thereof |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN102197049A Amylin derivatives |
| 09/21/2011 | CN102197048A Peptidomimetic macrocycles |
| 09/21/2011 | CN102197047A Mutant delta5 desaturases and their use in making polyunsaturated fatty acids |
| 09/21/2011 | CN102197046A Peptidomimetic marcrocycles |
| 09/21/2011 | CN102192984A Specific electrochemical immunosensor for tuberculosis serodiagnosis |
| 09/21/2011 | CN102191319A Oligonucleotide probes, for use in assessing gene transcript levels in a cell |
| 09/21/2011 | CN102191264A Production method of recombined hirudin |
| 09/21/2011 | CN102191256A Hypha mycin gene and karyogamy gene-engineering bacteria thereof |
| 09/21/2011 | CN102191255A Preparation and application of recombinant plectasin |
| 09/21/2011 | CN102191254A CBF transcription factor capable of regulating plant stress resistance, and coded gene and application thereof |
| 09/21/2011 | CN102191251A Method for expressing Cecropin CM4 gene in sf9 insect cells |
| 09/21/2011 | CN102191241A Engineering bacteria capable of producing fatty acid, and preparation method and application thereof |
| 09/21/2011 | CN102191240A Cloning and expressing method of tartary buckwheat trypsin inhibitor gene |
| 09/21/2011 | CN102191194A Bacillus subtilis and antibacterial protein thereof |
| 09/21/2011 | CN102190724A Chlordecone antigen and antibody and preparation method thereof |
| 09/21/2011 | CN102190723A Chromium ion antigen and preparation method and application thereof |
| 09/21/2011 | CN102190722A Purifying method for recombinant human serum albumin |
| 09/21/2011 | CN102190721A Long-acting growth hormone |
| 09/21/2011 | CN102190720A Method for preparing human glucagon-like peptide-2 (1-35 peptide) analogue |
| 09/21/2011 | CN102190719A Polyethylene glycol modified calcitonin |
| 09/21/2011 | CN102190718A Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 09/21/2011 | CN102190717A Narcissus tazetta lectin expressed in vitro and application thereof |
| 09/21/2011 | CN102190716A Perpetual bloom character related protein and coding gene thereof |
| 09/21/2011 | CN102190715A Protein related with arsenic resistance of plants, and coding gene and application thereof |
| 09/21/2011 | CN102190714A ELISA (Enzyme-linked immunosorbent assay) kit capable of identifying natural infection and artificial immune of foot-and-mouth disease virus |
| 09/21/2011 | CN102190713A Synthetic peptide and application thereof |
| 09/21/2011 | CN102190702A Method for raising crystallization rate of proteins |
| 09/21/2011 | CN102190701A Method for separating and purifying influenza virus hemagglutinin on large scale |
| 09/21/2011 | CN101602804B Method for preparing composition rich in alpha 1-antitrypsin from supernatant of a composition A+I by improved K-N method |
| 09/21/2011 | CN101538322B Polypeptide with inhibiting transcriptional activation activity of transcription factor, encoding gene thereof and application |
| 09/21/2011 | CN101392025B Plant anti-adversity associated protein and encoding gene and use thereof |
| 09/21/2011 | CN101376675B Antimicrobial peptide |
| 09/21/2011 | CN101296940B Peptides exhibiting efficacies of improvement in skin conditions or treatment of periodental diseases |
| 09/21/2011 | CN101257918B Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 09/21/2011 | CN101148673B Soybean abloom time adjusting gene GAL1 |
| 09/21/2011 | CN101092616B Expressing and purifying neutrophilic granule protein NGP |
| 09/21/2011 | CN101084238B Receptor selectivity lymphotoxin derivates |
| 09/20/2011 | US8022273 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 09/20/2011 | US8022271 Polyubiquitin Rubi3 promoter and 5' regulatory sequences |
| 09/20/2011 | US8022270 Expression of biologically active polypeptides in duckweed |
| 09/20/2011 | US8022197 Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene |
| 09/20/2011 | US8022196 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 09/20/2011 | US8022195 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair |
| 09/20/2011 | US8022191 PEG-conjugated erythropoietin |
| 09/20/2011 | US8022190 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 09/20/2011 | US8022189 Isolated antibodies against biologically active leptin-related peptides |
| 09/20/2011 | US8022187 Recombinant blood coagulation factor IX (rFIX) mutant having factor VIII (FVIII) independent factor X (FX) activation potential |
| 09/20/2011 | US8022186 Blood plasma protein for use as carrier medical therapeutics |
| 09/20/2011 | US8022185 IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/20/2011 | US8022184 IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/20/2011 | US8022183 IFBM'S to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/20/2011 | US8022182 Truncated BAFF receptors |
| 09/20/2011 | US8022178 Modified self-assembling peptides |
| 09/20/2011 | US8022176 FAS peptide mimetics and uses thereof |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022173 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8022045 Inhibitors of TGF-R-signaling for treatment of CNS disorders |
| 09/20/2011 | US8022039 Immunogenic HER-2 variants |
| 09/20/2011 | US8022035 Y4 selective receptor agonists for therapeutic interventions |
| 09/20/2011 | US8022031 Liquid composition of factor VII polypeptides |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021878 Regulatory switches for controlling insect development; biological pest control |
| 09/20/2011 | US8021867 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021859 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |
| 09/20/2011 | US8021852 Methods and compositions for detecting spermatozoa or semen in a sample |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021673 Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
| 09/20/2011 | US8021668 Integrin alpha L I domain mutants with increased binding affinity |
| 09/20/2011 | US8021666 Administering antigen; anticancer agents; transfection human cells |
| 09/20/2011 | US8021664 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 09/20/2011 | US8021659 Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2504377C Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| 09/20/2011 | CA2482512C Improved viral purification methods |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2454133C Isolation of membrane bound ligand-specific complexes |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2412075C Attenuated bovine respiratory syncytial virus |
| 09/20/2011 | CA2400562C Hybrid expression of neisserial proteins |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2331258C Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2319700C Methods of identifying genes involved in enhanced wound healing in mice |
| 09/20/2011 | CA2262403C Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |